Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05468008 · ClinicalTrials.gov registry record
Endoscopic Submucosal Dissection (ESD)
A clinical trial of Barrett Esophagus and Esophageal Lesion, sponsored by AdventHealth.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT05468008: Recruiting study of Barrett Esophagus and Esophageal Lesion, sponsored by AdventHealth.
NCT05468008 is a study of Barrett Esophagus and Esophageal Lesion that is actively recruiting participants, run by AdventHealth. The registered enrollment target is 1,000 participants, below the 3,534-participant average among 32 other Barrett Esophagus trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05468008, a study of Barrett Esophagus and Esophageal Lesion, is actively recruiting participants, sponsored by AdventHealth.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This registry is to evaluate the procedural and clinical outcomes in patients undergoing endoscopic submucosal dissection. All patients will receive standard of medical care and no experimental interventions will be performed.
Primary Outcome
The primary endpoint of this study will be the prospective evaluation of the utility of ESD for the endoscopic treatment of GI lesions.
Conditions Studied
Interventions
- PROCEDURE Endoscopic Submucosal Dissection
Study Locations (1)
Florida
- AdventHealth Orlando - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2022-02-04 |
| Est. Completion | 2027-12 |
What NCT05468008 shows while recruiting
NCT05468008 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 3,534-participant average among 32 other Barrett Esophagus trials with a reported enrollment target (72% lower).
The record links to 3 conditions, with Barrett Esophagus appearing as the primary indexed condition, and to 1 intervention - of which Endoscopic Submucosal Dissection is the first listed.
NCT05468008 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05468008 about?
NCT05468008 is a clinical study titled "Endoscopic Submucosal Dissection (ESD)". This registry is to evaluate the procedural and clinical outcomes in patients undergoing endoscopic submucosal dissection. All patients will receive standard of medical care and no experimental interventions will be performed.
What is the current status of trial NCT05468008?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2022-02-04. Estimated completion is 2027-12.
What conditions does trial NCT05468008 study?
This clinical trial studies the following conditions: Barrett Esophagus, Esophageal Lesion, Gastrointestinal Lesions.
What interventions are being tested in trial NCT05468008?
The interventions under investigation include: Endoscopic Submucosal Dissection (PROCEDURE).
Who is sponsoring clinical trial NCT05468008?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05468008 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Barrett Esophagus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05468008's enrollment target sits among peer trials
1,000 7th of 32 higher than 26 of 32 other Barrett Esophagus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Barrett Esophagus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
RECRUITING · NA
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
-
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
RECRUITING
-
Longitudinal Oral Microbiome Sampling for BE
RECRUITING
-
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
RECRUITING · NA
-
Non-Endoscopic Detection of Barrett's Esophagus Using Methylation Biomarkers on EndoSign® Cell Collection Device Samples
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI